2-Butenoic acid, 4-[[(5a,6a)-17-(cyclopropylmethyl)-4,5-epoxy-3,14-dihydroxymorphinan-6-yl]amino]-4-oxo-,methyl ester, (E)- (9CI) (83339-80-4)

Identification
Name:	2-Butenoic acid, 4-[[(5a,6a)-17-(cyclopropylmethyl)-4,5-epoxy-3,14-dihydroxymorphinan-6-yl]amino]-4-oxo-,methyl ester, (E)- (9CI)
Synonyms:	Morphinan,2-butenoic acid deriv.
CAS:	83339-80-4
Molecular Formula:	C25H30 N2 O6
Molecular Weight:	0
InChI:	InChI=1/C25H30N2O6/c1-32-20(30)7-6-19(29)26-16-8-9-25(31)18-12-15-4-5-17(28)22-21(15)24(25,23(16)33-22)10-11-27(18)13-14-2-3-14/h4-7,14,16,18,23,28,31H,2-3,8-13H2,1H3,(H,26,29)/b7-6+/t16-,18?,23+,24?,25?/m0/s1
Molecular Structure:
Properties
Flash Point:	374.2°C
Boiling Point:	695.2°C at 760 mmHg
Density:	1.43g/cm³
Refractive index:	1.674
Flash Point:	374.2°C
Safety Data

Other Product

2-Butenoic acid, 4-[[(5a,6b)-17-(cyclopropylmethyl)-4,5-epoxy-3,14-dihydroxymorphinan-6-yl]amino]-4-oxo-,methyl ester, (2E)-
2-Butenoic acid, 4-[[(5a,6b)-17-(cyclopropylmethyl)-4,5-epoxy-3,14-dihydroxymorphinan-6-yl]amino]-4-oxo-,methyl ester, hydrochloride (1:1), (2E)-
2-Butenoic acid,4-[[(5R)-17-(cyclopropylmethyl)- 4,5-epoxy-3-hydroxy-6- oxomorphinan-14-yl]amino]-4-oxo-,methyl ester
Acetamide, N-[(5a,6b)-17-(cyclopropylmethyl)-4,5-epoxy-3,14-dihydroxymorphinan-6-yl]-2-[methyl(7-nitro-2,1,3-benzoxadiazol-4-yl)amino]-(9CI)
2-Butenoic acid, 4-[[(5a,6b)-4,5-epoxy-3,14-dihydroxy-17-methylmorphinan-6-yl]amino]-14-hydroxy-4-oxo-,methyl ester, (2E)- (9CI)
2-Butenoicacid, 4-[[[(5a,7a)-17-(cyclopropylmethyl)-4,5-epoxy-18,19-dihydro-3-hydroxy-6-methoxy-6,14-ethenomorphinan-7-yl]methyl]amino]-4-oxo-,methyl ester, (2E)- (9CI)
Benzenepropanamide,4-chloro-N-[(5a)-17-(cyclopropylmethyl)-4,5-epoxy-3-hydroxy-6-oxomorphinan-14-yl]-(9CI)
2-Butenoic acid,4-[[(5R,7R)-17-(cyclopropylmethyl)- 4,5-epoxy-18,19-dihydro-3- hydroxy-6-methoxy-6,14-ethenomorphinan- 7-yl]amino]-4-oxo-,methyl ester,(2E)-
Acetamide,2-bromo-N-[(5a,6b)-17-(cyclopropylmethyl)-4,5-epoxy-3,14-dihydroxymorphinan-6-yl]-(9CI)
2-Propenamide, N-[(5a,6b)-17-(cyclopropylmethyl)-4,5-epoxy-3,14-dihydroxymorphinan-6-yl]-3-(3-furanyl)-N-methyl-,(2E)-
Morphinan-6-one,14-[[3-(4-chlorophenyl)propyl]amino]-17-(cyclopropylmethyl)-4,5-epoxy-3-hydroxy-,(5a)- (9CI)
2-Propenamide,3-(4-chlorophenyl)-N-[(5a)-17-(cyclopropylmethyl)-4,5-epoxy-3-hydroxy-6-oxomorphinan-14-yl]-, (2E)-
b-D-Glucopyranosiduronic acid, (5a)-17-(cyclopropylmethyl)-4,5-epoxy-14-hydroxy-6-oxomorphinan-3-yl(9CI)
2-Propenamide, N-[(5a,6b)-17-(cyclopropylmethyl)-4,5-epoxy-3,14-dihydroxymorphinan-6-yl]-3-(3-furanyl)-N-methyl-,hydrochloride (1:1), (2E)-
Acetamide,2-bromo-N-[(5a)-17-(cyclopropylmethyl)-4,5-epoxy-3-hydroxy-6-oxomorphinan-14-yl]-(9CI)
Acetamide, N-[(5a)-17-(cyclopropylmethyl)-4,5-epoxy-3-hydroxy-6-oxomorphinan-14-yl]-2-mercapto-(9CI)
Morphinan-6-ol,7,8-didehydro-4,5-epoxy-17-methyl-3-[2-(4-morpholinyl)ethoxy]-, 17-oxide, (5a,6a)- (9CI)
Pregn-5-en-20-one,3-hydroxy-, [(5a,6E)-17-(cyclopropylmethyl)-4,5-epoxy-3,14-dihydroxymorphinan-6-ylidene]hydrazone,(3b,20E)- (9CI)
Acetamide,2,2'-dithiobis[N-[(5a)-17-(cyclopropylmethyl)-4,5-epoxy-3-hydroxy-6-oxomorphinan-14-yl]- (9CI)
2-Propenamide, N-[[(5a,7a)-17-(cyclopropylmethyl)-4,5-epoxy-18,19-dihydro-3-hydroxy-6-methoxy-6,14-ethenomorphinan-7-yl]methyl]-3-(4-methylphenyl)-,(2E)- (9CI)